Cargando…

Pro-Inflammatory and Immunological Profile of Dogs with Myxomatous Mitral Valve Disease

SIMPLE SUMMARY: Myxomatous mitral valve disease (MMVD) is the most commonly acquired cardiac disease in dogs and is responsible for congestive heart failure. In this research, some inflammatory, immunological, and echocardiographic parameters were evaluated in dogs affected by MMVD in order to asses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piantedosi, Diego, Musco, Nadia, Palatucci, Anna Teresa, Carriero, Flavia, Rubino, Valentina, Pizzo, Francesco, Nasir, Saad, Molinaro, Giuseppe, Ruggiero, Giuseppina, Terrazzano, Giuseppe, Lombardi, Pietro, Cortese, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315642/ https://www.ncbi.nlm.nih.gov/pubmed/35878343 http://dx.doi.org/10.3390/vetsci9070326

Ejemplares similares

Effect of a Weight Loss Program on Biochemical and Immunological Profile, Serum Leptin Levels, and Cardiovascular Parameters in Obese Dogs
por: Piantedosi, Diego, et al.
Publicado: (2020)

An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?
por: Terrazzano, Giuseppe, et al.
Publicado: (2020)

Clinical and Immunological Response in Dogs Naturally Infected by L. infantum Treated with a Nutritional Supplement
por: Lombardi, Pietro, et al.
Publicado: (2019)

Bone marrow CD3 (+) CD56 (+) regulatory T lymphocytes (T(R3) (−56) cells) are inversely associated with activation and expansion of bone marrow cytotoxic T cells in IPSS‐R very‐low/low risk MDS patients
por: Leone, Stefania, et al.
Publicado: (2022)

Myxomatous degeneration of the mitral valve
por: Neto, Felippe Lazar, et al.
Publicado: (2018)

Superoxide Dismutase-1 Intracellular Content in T Lymphocytes Associates with Increased Regulatory T Cell Level in Multiple Sclerosis Subjects Undergoing Immune-Modulating Treatment
por: Rubino, Valentina, et al.
Publicado: (2021)

Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease
por: Rubino, Valentina, et al.
Publicado: (2023)

Myxomatous Mitral Valve with Prolapse and Flail Scallop
por: Fan, Jerry, et al.
Publicado: (2016)

Knockdown of PTGS2 by CRISPR/CAS9 System Designates a New Potential Gene Target for Melanoma Treatment
por: Ercolano, Giuseppe, et al.
Publicado: (2019)

Insights on the Multifaceted Roles of Wild-Type and Mutated Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis Pathogenesis
por: Rubino, Valentina, et al.
Publicado: (2023)

P711: THE PREVALENCE OF FOXP3-E2 ISOFORM IN REGULATORY T CELLS CORRELATES WITH THE DEGREE OF DYSPLASIA IN MYELODYSPLASTIC SYNDROMES
por: Leone, Stefania, et al.
Publicado: (2023)

Plasmatic Dimethylarginines in Dogs With Myxomatous Mitral Valve Disease
por: Valente, Carlotta, et al.
Publicado: (2021)

Intestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas
por: Araki, R., et al.
Publicado: (2021)

Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker
por: Savarese, Alice, et al.
Publicado: (2018)

In Vitro Effects of Some Botanicals with Anti-Inflammatory and Antitoxic Activity
por: Guidetti, Gianandrea, et al.
Publicado: (2016)

Telotristat ethyl reverses myxomatous changes in mice mitral valves
por: Wang, Xinmei, et al.
Publicado: (2022)

A Genomic Study of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels
por: Bionda, Arianna, et al.
Publicado: (2020)

Myxomatous Mitral Valve Disease with Mitral Valve Prolapse and Mitral Annular Disjunction: Clinical and Functional Significance of the Coincidence
por: Wunderlich, Nina C., et al.
Publicado: (2021)

Leptin and Immunological Profile in Obesity and Its Associated Diseases in Dogs
por: Cortese, Laura, et al.
Publicado: (2019)

Oxytetracycline induces DNA damage and epigenetic changes: a possible risk for human and animal health?
por: Gallo, Adriana, et al.
Publicado: (2017)

Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease
por: Kim, H.‐S., et al.
Publicado: (2016)

Review of Diagnostic and Therapeutic Approach to Canine Myxomatous Mitral Valve Disease
por: Menciotti, Giulio, et al.
Publicado: (2017)

Assessment of heart rate turbulence in dogs with myxomatous mitral valve disease
por: dos Santos, Julio P., et al.
Publicado: (2021)

Hemodynamic Effects of Protamine Infusion in Dogs with Myxomatous Mitral Valve Disease Undergoing Mitral Valvuloplasty
por: Yoshida, Tomohiko, et al.
Publicado: (2022)

The Mitral INsufficiency Echocardiographic score: A severity classification of myxomatous mitral valve disease in dogs
por: Vezzosi, Tommaso, et al.
Publicado: (2021)

Mapping of the myxomatous mitral valve: The three-dimensional extension of mitral annular disjunction in surgically repaired mitral prolapse
por: Biondi, Raoul, et al.
Publicado: (2022)

Toxicological Implications and Inflammatory Response in Human Lymphocytes Challenged with Oxytetracycline
por: Di Cerbo, A., et al.
Publicado: (2015)

Mitral annular disjunction in myxomatous mitral valve disease: a relevant abnormality recognizable by transthoracic echocardiography
por: Carmo, Pedro, et al.
Publicado: (2010)

Distinct Mitral Valve Proteomic Profiles in Rheumatic Heart Disease and Myxomatous Degeneration
por: Martins, Carlo de Oliveira, et al.
Publicado: (2014)

Contractile properties of the right atrial myofilaments in patients with myxomatous mitral valve degeneration
por: Bening, Constanze, et al.
Publicado: (2014)

Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease
por: Li, Qinghong, et al.
Publicado: (2015)

Prevalence and Prognostic Importance of Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease
por: Borgarelli, M., et al.
Publicado: (2015)

Predictive model for the detection of pulmonary hypertension in dogs with myxomatous mitral valve disease
por: MIKAWA, Shoma, et al.
Publicado: (2014)

Genomic analysis in patients with myxomatous mitral valve prolapse: current state of knowledge
por: Gasser, S., et al.
Publicado: (2018)

Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs
por: Nakamura, K., et al.
Publicado: (2017)

ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs
por: Keene, Bruce W., et al.
Publicado: (2019)

Prevalence and risk factors for atrial fibrillation in dogs with myxomatous mitral valve disease
por: Guglielmini, Carlo, et al.
Publicado: (2020)

Radiographic quantification of left atrial size in dogs with myxomatous mitral valve disease
por: Lam, Christopher, et al.
Publicado: (2021)

The Role of Transforming Growth Factor-β Signaling in Myxomatous Mitral Valve Degeneration
por: Tang, Qiyu, et al.
Publicado: (2022)

Serum Proteomic Profiles Reflect the Stages of Myxomatous Mitral Valve Disease in Dogs
por: Rešetar Maslov, Dina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fa6pr83huaipnpvvkp6rtcelms